Viewing Study NCT03785756


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT03785756
Status: COMPLETED
Last Update Posted: 2024-06-03
First Post: 2018-12-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars
Sponsor: Reckitt Benckiser Healthcare (UK) Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-04-29
Start Date Type: ACTUAL
Primary Completion Date: 2020-02-20
Primary Completion Date Type: ACTUAL
Completion Date: 2020-02-28
Completion Date Type: ACTUAL
First Submit Date: 2018-12-17
First Submit QC Date: None
Study First Post Date: 2018-12-24
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-05-12
Results First Submit QC Date: None
Results First Post Date: 2024-06-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-31
Last Update Post Date: 2024-06-03
Last Update Post Date Type: ACTUAL